TP53BP1 and metabolic dysfunction-associated steatotic liver disease: These results are in agreement with very recent data from Akazawa et al. showing that the marker of the DNA damage response, the p53-binding protein 1 (53BP1), is associated with disease progression in patients with non-alcoholic fatty liver disease (NAFLD), particularly in those with more severe disease characterized by liver fibrosis [32].